Table 1 Patient characteristics
|  | TAC + ZA N = 122 (49.6%) | TAC N = 124 (50.4%) | IGF-1R biopsy data available N = 188 (76.4%) | Serum data available N = 37 (15%) |
|---|---|---|---|---|
Median age (range), Years | 48.0 (29–67) | 49.0 (34–70) | 49 (29–70) | 49 (34–65) |
Median BMI (range), kg/m2 | 26.1 (18.5–40.0) | 25.0 (18.3–42.0) | 25.0 (18.3–42.0) | 24.9 (19.4–39.5) |
Menopausal status | ||||
 Pre/peri | 72 (59.0%) | 75 (60.5%) | 110 (58.5%) | 24 (64.9%) |
 Post | 50 (41.0%) | 47 (37.9%) | 76 (40.4%) | 13 (35.1%) |
T-classification | ||||
 T1/T2 | 73 (59.8%) | 71 (57.3%) | 108 (57.4%) | 21 (56.8%) |
 T3/T4 | 49 (40.2%) | 53 (42.7%) | 80 (42.6%) | 16 (43.2%) |
N-classification | ||||
 N0 | 54 (44.3%) | 56 (45.2%) | 90 (47.9%) | 22 (59.5%) |
 N+ | 68 (55.7%) | 68 (54.8%) | 98 (52.1%) | 15 (40.5%) |
HR-status | ||||
 ER+ and/or PR+ | 101 (82.8%) | 104 (83.9%) | 158 (84.0%) | 33 (89.2%) |
 ER− and PR− | 21 (17.2%) | 20 (16.1%) | 30 (16.0%) | 4 (10.8%) |